Post-Approval CMC Changes: The ICH Q12 Compliance Gap Hiding in Plain Sight2026-06-01ICH Q12 lifecycle management creates post-approval CMC compliance gaps that most MAHs identify too late. Vestango maps the risk surface before the clock starts.Read more
ICH E5(R1) Bridging Data Gaps in Global Clinical Trials2026-05-28ICH E5(R1) bridging study requirements and ethnic factors analysis in global clinical development — how data architecture gaps trigger Day 80 deficiencies in centralised procedure submissions.Read more
FDA Warning Letters and the GMP Data Gap Importers Miss2026-05-26FDA Warning Letters under 21 CFR Part 211 reveal a recurring GMP data architecture gap in foreign manufacturing sites. Vestango delivers scored compliance profiles in 48 hours.Read more
Real-World Data Gaps That Stall Biotech Assets Before Day 02026-05-21ICH M14 entered into effect 18 March 2026. Biotech assets with unresolved RWD architecture gaps face Day 80 deficiency risk. Vestango delivers scored compliance profiles.Read more
Gene Therapy Nonclinical Dossiers: Where Biotech Assets Lose Value2026-05-18ICH S12 biodistribution gaps in gene therapy nonclinical dossiers create Day 80 deficiency risk. Vestango delivers scored eCTD readiness profiles before assessment clock starts.Read more
Pharma Compliance Dashboard: When Regulatory Intelligence Breaks2026-05-18When pharma compliance dashboards fail to track ICH Q12 changes, Ph.Eur. interchangeability, and cross-registry signals, the cost hits before Day 0. Vestango fixes this.Read more
